About RoosterBio
RoosterBio is a Healthcare company based in Frederick (United States) founded in 2012 by Jon Rowley. Developer of human mesenchymal stem cells and extracellular vesicles. RoosterBio has raised $38.41 million across 8 funding rounds from investors including HHS, Vanedge Capital and Bioeconomy Capital. Its chief executive, as recorded, is Tim Kelly. Its website roosterbio.com draws about 11 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Cell Culture. Its legal entity is RoosterBio, Inc. Its competitors include BioLife Solutions, ArunA Bio and Prolific Machines; 2 of its 3 listed competitors have raised funding.
Company details
RoosterBio was founded in 2012 and is headquartered in Frederick, United States. Operations center on the biotechnology sector, where human bone marrow-derived and adipose-derived mesenchymal stem cells are produced alongside specialized media formulations for cell expansion. Extracellular vesicles associated with these cells are also developed. The companys activities support stem cell research and therapeutic applications in a controlled manufacturing environment.
- Headquarters Frederick, United States
- Founders Jon Rowley
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website roosterbio.com
- Social LinkedIn X Facebook YouTube
- Legal Name Roosterbio, Inc.
- Total Equity Funding$38.41M (USD)
in 8 rounds
- InvestorsHHS
& 4 more
Apps and channels of RoosterBio
its YouTube channel RoosterBio, Inc. has 90 subscribers and 12 videos.
Videos from RoosterBio
The most watched videos on RoosterBio's YouTube channel, RoosterBio, Inc. (90 subscribers). Click a video to play it here.
More on RoosterBio, Inc..
Funding Insights of RoosterBio
RoosterBio has successfully raised a total of $38.41M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.41M
- Total Rounds 8
- First Round $250,000
(Feb 2014)
- Investors Count 5
All 8 funding rounds of RoosterBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $12M | Series B | – | – | – |
| Mar 2024 | Debt – Conventional | – | – | – | |
| Sep 2019 | $21.5M | Series B | – | Dynamk Capital | |
| Oct 2017 | Grant | – | – | ||
| Jan 2017 | $1.25M | Series A | – | – | – |
| Nov 2016 | $3.41M | Series A | – | – | – |
| Sep 2015 | $432,120 | Grant | – | – | |
| Feb 2014 | $250,000 | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in RoosterBio
RoosterBio has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Vanedge Capital and Bioeconomy Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital is invested in US and Canadian companies. | vanedgecapital.com | Vancouver, Canada | ||
| bioeconomycapital.com | ||||
Investment in life sciences innovation is facilitated by Dynamk Capital. | dynamk.vc | New York, United States | ||
Stem cell research startups in healthcare are funded and accelerated. | mscrf.org | Columbia, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for RoosterBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RoosterBio
31 people are tracked at RoosterBio (9 in leadership, 10 in board & advisors, 12 in team).
| Name | Role | Group |
|---|---|---|
Jon Rowley | Founder | Leadership |
Tim Kelly | CEO | Leadership |
Megan Brittain | Director, Manufacturing Operations | Leadership |
Jon A. Rowley | Founder & Chief Product Officer | Leadership |
Matt Drew | VP, Sales & Marketing | Leadership |
Thomas Higgs | Associate Director of Quality Control | Leadership |
Nicholas Trotter-Mayo | Senior Director - Global Sales | Leadership |
William King, PhD | Director Of Business Development | Leadership |
Joseph Candiello, PhD | Associate Director, Product Management | Leadership |
Prem Ramaswami | Advisor | Board & advisors |
Rob Carlson | Director | Board & advisors |
Makarand Jawadekar | Advisor | Board & advisors |
Aby Mathew | Advisor | Board & advisors |
R. Lee Buckler | Advisor | Board & advisors |
Daniella Kranjac | Director | Board & advisors |
Andras Forgacs | Advisor | Board & advisors |
Phil Vanek | Advisor | Board & advisors |
Martin C. Peters | Advisor | Board & advisors |
Robert Preti | Director | Board & advisors |
Amy Permenter | Senior Customer Success Representative | Team |
11 more people are available in the full profile.
Complete people profiles for RoosterBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RoosterBio
3 dated milestones of RoosterBio across 12 years, from founding to its latest funding, stage changes and deals.
- Founded RoosterBio is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Debt – Conventional,.
Competitors of RoosterBio
RoosterBio has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, ArunA Bio and Prolific Machines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| arunabio.com | 2017 | Athens, United States | $38.51M | Neural exosome platform is developed for neurodegenerative disease therapeutics. | ||
| prolific-machines.com | 2020 | United States | $55M | Photomolecular biology platform is provided for controlling cellular functions dynamically. |
Detailed competitors of RoosterBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RoosterBio
The website of RoosterBio (roosterbio.com) receives about 10.8K visits a month and ranks #2,915,727 among all websites worldwide, #3,898 in Biotechnology and Pharmaceuticals.
- Monthly visits10.8K
▲ 39.9% vs previous month
- Unique visitors3.3K
per month
- Global rank#2,915,727
among all websites
- Category rank#3,898
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.5
- Average visit11 sec
- DevicesDesktop 34% · Mobile 66%
Top companies in Cell Therapy
3 companies that operate in the same segment as RoosterBio (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Roosterbio
Complete news archive for RoosterBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RoosterBio
RoosterBio was founded in 2012 and raised its 1st funding round 2 years after it was founded.
RoosterBio is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Tim Kelly is the CEO of RoosterBio, as recorded in our data.
RoosterBio is a funded company, having raised a total of $38.41M across 8 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Feb 2014.
RoosterBio was founded in 2012 and is headquartered in Frederick, United States. Operations center on the biotechnology sector, where human bone marrow-derived and adipose-derived mesenchymal stem cells are produced alongside specialized media formulations for cell expansion. Extracellular vesicles associated with these cells are also developed. The companys activities support stem cell research and therapeutic applications in a controlled manufacturing environment.
RoosterBio's top competitors include Prolific Machines, BioLife Solutions and ArunA Bio.
RoosterBio has 5 investors. Key investors include HHS, Vanedge Capital, Bioeconomy Capital, Dynamk Capital, and Maryland Stem Cell Research Fund.
RoosterBio operates through Roosterbio, Inc..